Go to Contents Go to Navigation

Bioneer wins approval for clinical trials of COVID-19, influenza kits

All News 09:43 September 17, 2020

SEOUL, Sept. 17 (Yonhap) -- South Korean small drug firm Bioneer Corp. said Thursday it has won approval from the local drug safety watchdog to conduct a clinical trial of multi-diagnostic kits that can detect both the novel coronavirus and seasonal influenza.

The Ministry of Food and Drug Safety has given the green light to the two kits that can simultaneously check for the COVID-19 virus and both type A and B influenza infection, it said.

This undated image, captured from the website of Bioneer Corp., shows the company's corporate logo. (PHOTO NOT FOR SALE) (Yonhap)

As autumn is approaching, local pharmaceutical companies have joined the race to develop multi-purpose kits to tackle both COVID-19 and the flu, as it is not easy to distinguish coronavirus and flu patients due to their similar symptoms, such as coughing, a sore throat and fever.

"There is rising demand from other countries for the multi-purpose kit. We are rushing to export it in early October," said a company official, who asked not to be named.

Bioneeer said it also is in the process of a separate clinical trial for European approval.

Another similar product earlier received approval for clinical trials from the ministry.

If the use of the test kits is approved, it is expected to shorten the time taken to receive test results, compared with the time for two separate tests.

khj@yna.co.kr
(END)

Keywords
Issue Keywords
Most Liked
Most Saved
Most Viewed More
HOME TOP
Send Feedback
How can we improve?
Thanks for your feedback!